Dimitrios ATHANASIOU

Dimitrios Athanasiou holds a BA in Business Administration and an MBA in Financial Management. He speaks three European languages and has more than 25 years’ experience with international business projects, working in various countries in consulting, developing and reorganizing companies.
When his son was diagnosed with Duchenne Muscular Dystrophy, a fatal and incurable rare disease, he become a strong international patient advocate in Duchenne and Rare Diseases.
He became a board member of the World Duchenne Organization (WDO), was a board member in European Patient Forum EPF , the umbrella of the patient organizations in Europe, serves on the Board of Greek Patients Association and is a VP in Rare Diseases Greece.
As a strong and committed patient advocate for DMD and rare diseases, he serves the patient community through various roles.
In 2014 he was nominated patient expert by EMA for DMD and has participated in several of EMA's Scientific Advice, SAG, Protocol Assistance and CHMP pilot meetings for Duchenne, providing the essential patient representative perspective when companies request regulatory advice or approval.
He was a PDCO member in European Medicines Agency till 2023 and currently a PCWP member.